Handschin J C, Handloser K, Takahashi A, Eppenberger U
Cancer Res. 1983 Jun;43(6):2947-54.
The cyclic adenosine 3':5'-monophosphate (cAMP)-binding proteins of dysplastic (control) and neoplastic human breast tissue cytosols were investigated after photoaffinity labeling with 8-azido-cyclic adenosine 3':5'-[32P]monophosphate (8-N3-cAMP) by sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Four main binding proteins, all specific for cAMP, were identified, with molecular weights of 52,000, 49,000, 39,000, and 37,000. According to their molecular weights, elution on diethylaminoethyl cellulose, and in vitro phosphorylation, the Mr 49,000 and 52,000 species correspond to the regulatory subunits (R-I, R-II) of cAMP-dependent protein kinases types I and II. The smaller cAMP receptors (Mr 39,000 and 37,000) are proteolytic fragments of the intact R-proteins. Dissociation constants (Kd) with 8-N3-cAMP of 0.8 nM for R-I, and 0.12 microM for R-II were obtained; the proteolytic fragments exhibited Kd's similar to that of R-I. No difference in the 8-N3-cAMP affinities and labeling efficiencies was found between control and neoplastic tissues. Although the average incorporation of 8-N3-cAMP was 0.29 +/- 0.02 (S.E.) pmol/mg protein for control and 0.45 +/- 0.06 pmol/mg protein for neoplastic breast tissue cytosol, this difference does not reflect different cellular concentrations of cAMP receptors since the content of blood protein components is lower in tumor tissue. However, tumor cytosols exhibited an increased content of proteolytic R-fragments, and the ratio of intact cAMP receptors versus proteolyzed R-proteins was significantly (p less than 0.01) higher in control (8.3 +/- 0.9) than in tumor (3.0 +/- 0.5) tissue. The average R-I/R-II ratio was greater than 1 in each case, but no significant difference was observed between control and neoplastic tissue. Inverse relationships were obtained, especially between proteolyzed R-fragments and estrogen receptors, when the contents and ratios of cAMP-binding proteins were correlated with the contents of estrogen and progesterone receptors in tumor tissue by a Spearman rank correlation coefficient r = -0.55 (significance of difference from zero being p less than 0.01).
在用8-叠氮基环腺苷3':5'-[32P]单磷酸(8-N3-cAMP)进行光亲和标记后,通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳研究了发育异常(对照)和肿瘤性人乳腺组织胞质溶胶中的环腺苷3':5'-单磷酸(cAMP)结合蛋白。鉴定出四种主要的cAMP特异性结合蛋白,分子量分别为52,000、49,000、39,000和37,000。根据其分子量、在二乙氨基乙基纤维素上的洗脱情况以及体外磷酸化情况,分子量为49,000和52,000的蛋白分别对应于I型和II型cAMP依赖性蛋白激酶的调节亚基(R-I、R-II)。较小的cAMP受体(分子量39,000和37,000)是完整R蛋白的蛋白水解片段。测得R-I与8-N3-cAMP的解离常数(Kd)为0.8 nM,R-II为0.12 microM;蛋白水解片段的Kd与R-I相似。对照组织和肿瘤组织之间在8-N3-cAMP亲和力和标记效率上没有差异。尽管对照组织中8-N3-cAMP的平均掺入量为0.29±0.02(标准误)pmol/mg蛋白,肿瘤性乳腺组织胞质溶胶中为0.45±0.06 pmol/mg蛋白,但这种差异并不反映cAMP受体的细胞浓度不同,因为肿瘤组织中血蛋白成分的含量较低。然而,肿瘤胞质溶胶中蛋白水解的R片段含量增加,对照组织(8.3±0.9)中完整cAMP受体与蛋白水解的R蛋白的比例显著(p<0.01)高于肿瘤组织(3.0±0.5)。每种情况下R-I/R-II的平均比值均大于1,但对照组织和肿瘤组织之间未观察到显著差异。当通过Spearman等级相关系数r = -0.55(与零差异的显著性为p<0.01)将肿瘤组织中cAMP结合蛋白的含量和比值与雌激素和孕激素受体的含量相关联时,得到了相反的关系,尤其是蛋白水解的R片段与雌激素受体之间。